755C Whellan, David - Thomas Jefferson University
Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Whellan, David

< Back

Profile

djw150

David J. Whellan, MD, MHS, FACC, FAHA

Contact Dr. Whellan

925 Chestnut Street
Mezzanine
Philadelphia, PA 19107

(215) 955-2636
(215) 503-7420 fax

Medical School

MD, Washington University School of Medicine
Master Health Science in Clinical Research, Duke University

Residency

Hospital of University of Pennsylvania (HUP)

Fellowship

Clinical Cardiology, Duke University Medical Center

Board Certification

Internal Medicine
Cardiovascular Disease

Hospital Appointment

Thomas Jefferson University Hospital

Expertise & Research Interests

Dr. Whellan is the Co-Principal Investigator of the HF-ACTION study, a NIH grant for research in heart failure and exercise training. In addition, he has served as the national PI for the PARTNERS HF study and currently sits on the steering committee for the ASCEND and TRACER-ACS trials.

He has authored over 100 peer-reviewed articles, reviews, abstracts, and book chapters on cardiomyopathy; and is an associate editor for American Heart Journal.

Publications

Most Recent Peer-Reviewed Publications

  1. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk
  2. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers
  3. Effect of early intervention with positive airway pressure therapy for sleep disordered breathing on six-month readmission rates in hospitalized patients with heart failure
  4. Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study
  5. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial
  6. Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds
  7. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias
  8. Erratum: Corrigendum to exercise training for chronic heart failure (ExTraMATCH II): Protocol for an individual participant data meta-analysis (Int J Cardiol. (2014) 174:3 (683-687) DOI: http://dx.doi.org/10.1016/j.ijcard.2014.04.203)
  9. Exercise training and pacing status in patients with heart failure: Results from HF-ACTION
  10. Prognostic Significance of Depression in Blacks with Heart Failure: Insights from Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training
  11. Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure
  12. Evaluation of the incremental prognostic utility of increasingly complex testing in chronic heart failure
  13. Team-Based Care for Managing Cardiac Comorbidities in Heart Failure
  14. Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee
  15. Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)
  16. Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure
  17. Photoplethysmographic Signal to Screen Sleep-Disordered Breathing in Hospitalized Heart Failure Patients: Feasibility of a Prospective Clinical Pathway
  18. Authorship in a multicenter clinical trial: The heart failure - A controlled trial investigating outcomes of exercise training (HF-ACTION) authorship and publication (HAP) scoring system results
  19. Exercise training as therapy for heart failure current status and future directions
  20. Advanced (stage D) heart failure: A statement from the heart failure society of america guidelines committee
0